Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Net Income towards Common Stockholders: 2023-2024

Historic Net Income towards Common Stockholders for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$76.4 million.

  • Upstream Bio's Net Income towards Common Stockholders fell 60.45% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.8 million, marking a year-over-year decrease of 76.43%. This contributed to the annual value of -$76.4 million for FY2024, which is 99.70% down from last year.
  • According to the latest figures from FY2024, Upstream Bio's Net Income towards Common Stockholders is -$76.4 million, which was down 99.70% from -$38.3 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Net Income towards Common Stockholders registered a high of -$38.3 million during FY2023, and its lowest value of -$76.4 million during FY2024.
  • Its 2-year average for Net Income towards Common Stockholders is -$57.3 million, with a median of -$57.3 million in 2023.
  • Data for Upstream Bio's Net Income towards Common Stockholders shows a maximum YoY tumbled of 99.70% (in 2024) over the last 5 years.
  • Upstream Bio's Net Income towards Common Stockholders (Yearly) stood at -$38.3 million in 2023, then plummeted by 99.70% to -$76.4 million in 2024.